Effect of Gemigliptin on Metabolic Endotoxemia and Lipemia

Summary

This is an exploratory study on the metabolic endotoxemia associated with type 2 diabetes. The investigators will measure systemic endotoxin level and lipid level after ingestion of high fat diet to evaluate the effect of gemigliptin, a DPP-4 inhibitor, on metabolic endotoxemia and lipemia induced by high fat diet.

Timeline

Start

2014-07

Primary completion

2015-07

Completion

2015-07

Drugs

Indications